Director / PDMR Shareholding
Director: Dr
Transaction: issue of 20,000,000 shares on
Price:
Total shares held by Dr
These shares shall rank pari passu in all respects with the existing ordinary shares of
Following these allotments, the total number of issued shares and the total number of voting rights in the Company is 187,292,810. The total issued share capital is now
The above figure of 187,292,810 should be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the Financial Conduct Authority's Disclosure and Transparency Rules.
Notification of a Transaction pursuant to Article 19(1) of Regulation (EU) No. 596/2014/Appendix 3, Part II of the AQSE Growth Market Rules for Issuers:
1. Details of the person discharging managerial responsibilities/persons closely associated
a.
2. Reason for the Notification
a. Position/Status: Executive Chairman
b. Initial Notification/Amendment: Initial
3. Details of Issuer
a.
b. LEI: 213800AMGNBSOCOSDN11
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a. Description of the financial instrument, type of instrument/Identification code (ISIN): Ordinary Shares of
b. Nature of the transaction: On market purchase
c. Price(s) and volume(s):
Price Volume
d. Aggregated information:
Aggregated volume Price
20,000,000
e. Date and time of the transaction:
f. Place of the transaction:
The Directors of
For further information please contact:
Executive Director
Aquis Stock Exchange Corporate Adviser
Tel: +44 (0) 203 772 0021
Financial Advisor
Ross.Andrews@guildfin.co.uk
Tel: +44 (0) 7894008100
END
This information is provided by RNS, the news service of the